<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bone Res</journal-id><journal-id journal-id-type="iso-abbrev">Bone Res</journal-id><journal-title-group><journal-title>Bone Research</journal-title></journal-title-group><issn pub-type="ppub">2095-4700</issn><issn pub-type="epub">2095-6231</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28392965</article-id><article-id pub-id-type="pmc">5360159</article-id><article-id pub-id-type="pii">boneres20178</article-id><article-id pub-id-type="doi">10.1038/boneres.2017.8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mechanosignaling activation of TGF&#x003b2; maintains intervertebral disc homeostasis</article-title><alt-title alt-title-type="running">TGF&#x003b2; in IVD homeostasis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bian</surname><given-names>Qin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Amit</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Crane</surname><given-names>Janet L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kebaish</surname><given-names>Khaled</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wan</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhengdong</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Edward Guo</surname><given-names>X</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sponseller</surname><given-names>Paul D</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e9;guin</surname><given-names>Cheryle A</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Riley</surname><given-names>Lee H</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yongjun</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><aff id="aff1"><label>1</label><institution>Department of Orthopaedic Surgery, Institute for Cell Engineering, Johns Hopkins University</institution>, Baltimore, MD, <country>USA</country></aff><aff id="aff2"><label>2</label><institution>Institute of Spine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine</institution>, Shanghai, <country>PR China</country></aff><aff id="aff3"><label>3</label><institution>Department of Pediatrics, Johns Hopkins University</institution>, Baltimore, MD, <country>USA</country></aff><aff id="aff4"><label>4</label><institution>Department of Biomedical Engineering, Columbia University</institution>, NY, <country>USA</country><country/></aff><aff id="aff5"><label>5</label><institution>Departments of Physiology and Pharmacology, University of Western Ontario</institution>, London, <country>Canada</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label>
(<email>xcao11@jhmi.edu</email>)</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>03</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>5</volume><fpage>17008</fpage><lpage/><history><date date-type="received"><day>08</day><month>01</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>01</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 The Author(s)</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>The Author(s)</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p>Intervertebral disc (IVD) degeneration is the leading cause of disability with no disease-modifying treatment. IVD degeneration is associated with instable mechanical loading in the spine, but little is known about how mechanical stress regulates nucleus notochordal (NC) cells to maintain IVD homeostasis. Here we report that mechanical stress can result in excessive integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>-mediated activation of transforming growth factor beta (TGF&#x003b2;), decreased NC cell vacuoles, and increased matrix proteoglycan production, and results in degenerative disc disease (DDD). Knockout of TGF&#x003b2; type II receptor (T&#x003b2;RII) or integrin &#x003b1;<sub>v</sub> in the NC cells inhibited functional activity of postnatal NC cells and also resulted in DDD under mechanical loading. Administration of RGD peptide, TGF&#x003b2;, and &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>-neutralizing antibodies attenuated IVD degeneration. Thus, integrin-mediated activation of TGF&#x003b2; plays a critical role in mechanical signaling transduction to regulate IVD cell function and homeostasis. Manipulation of this signaling pathway may be a potential therapeutic target to modify DDD.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p>Degenerative disc disease (DDD) remains a common musculoskeletal disorder that brings an enormous socioeconomic burden.<sup><xref ref-type="bibr" rid="bib1 bib2 bib3">1&#x02013;3</xref></sup> Although numerous factors associated with DDD have been identified, the exact molecular pathogenesis of DDD has yet to be elucidated. The current treatments focus on symptomatic relief from pain through injections, physical therapy, and activity modification<sup><xref ref-type="bibr" rid="bib4">4</xref></sup> or surgical intervention such as disc decompression, spinal fusion, and disc replacement.<sup><xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib5">5</xref></sup> However, none of these interventions halt the progression of degeneration nor restore the physiologic disc function.</p><p>Dysfunction of nucleus pulposus (NP) cells is the key in the onset of intervertebral disc (IVD) degeneration.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib6 bib7 bib8">6&#x02013;8</xref></sup> It is known that NP cells are of notochord origin,<sup><xref ref-type="bibr" rid="bib9 bib10 bib11">9&#x02013;11</xref></sup> termed as notochordal (NC) cells at early age. NC cells are large with intracellular vacuoles making up at least 25% of the cell area.<sup><xref ref-type="bibr" rid="bib7">7</xref>,<xref ref-type="bibr" rid="bib8">8</xref></sup> The large vacuoles generate IVD space during spinal morphogenesis.<sup><xref ref-type="bibr" rid="bib9">9</xref>,<xref ref-type="bibr" rid="bib12 bib13 bib14">12&#x02013;14</xref></sup> During maturation and degeneration, the NC cells undergo morphologic and functional transition with the loss of their vacuoles. The resultant fibroblast-like cells have decreased the expression of extracellular matrix protein such as aggrecan,<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> which enables the NP to maintain height and turgor against compressive loads via its osmotic properties.<sup><xref ref-type="bibr" rid="bib16">16</xref>,<xref ref-type="bibr" rid="bib17">17</xref></sup> The mechanism driving NC cell transition is unclear, particularly how the mechanical load influences cell signaling.</p><p>Temporal&#x02013;spatial activation of latent matrix transforming growth factor beta (TGF&#x003b2;) has been shown to modulate chondrocyte anabolic activity in articular cartilage, maintain bone homeostasis during bone remodeling, and help with tissue repair.<sup><xref ref-type="bibr" rid="bib18">18</xref>,<xref ref-type="bibr" rid="bib19">19</xref></sup> The &#x003b1;<sub>v</sub> integrins in combination with -&#x003b2;<sub>6</sub>, -&#x003b2;<sub>5</sub>, and -&#x003b2;<sub>8</sub> have been shown to mediate the activation of TGF&#x003b2;.<sup><xref ref-type="bibr" rid="bib20 bib21 bib22 bib23 bib24">20&#x02013;24</xref></sup> Integrins enable cells to transduce mechanical loads into biological signaling. As NP cells express &#x003b1;<sub>v</sub> and multiple &#x003b2; integrin subunits, integrin-mediated activation of TGF&#x003b2; may play a critical role in IVDs.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> In addition, active TGF&#x003b2; is known to act upstream of connective tissue growth factor (CTGF/CCN2) and aggrecan, both of which are involved in DDD development.<sup><xref ref-type="bibr" rid="bib26">26</xref>,<xref ref-type="bibr" rid="bib27">27</xref></sup> Thus, we sought to understand the role of TGF&#x003b2; in IVD homeostasis.</p><p>In this study, we systematically investigated the role of mechanical stress on the functional transition of NC cells and IVD homeostasis. Utilizing multiple rodent models, we found that mechanical stress resulted in integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>-mediated activation of TGF&#x003b2;. Abnormal stress resulted in excessive TGF&#x003b2; signaling and accelerated NC cells functional transition. Administration of RGD peptide and neutralizing antibodies against TGF&#x003b2; and &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> attenuated these changes. On the other hand, conditional knockout of T&#x003b2;RII or &#x003b1;<sub>v</sub> also impeded NC cells&#x02019; transition and caused IVD degeneration by mechanical stimuli. Thus, precise integrin-induced activation of TGF&#x003b2; is required to maintain IVD cell function and homeostasis.</p></sec><sec><title>Materials and methods</title><sec><title>Subjects</title><sec><title>Animal models</title><sec><title>Lumbar spine instability mouse model</title><p>C57BL/6J (male, 8-week old) mice were purchased from Charles River, Wilmington, MA, USA. After anesthetized with ketamine and xylazine, they were operated by resection of the lumbar 3th&#x02013;lumbar 5th (L<sub>3</sub>&#x02013;L<sub>5</sub>) spinous processes along with the supraspinous and interspinous ligaments to induce instability of lumbar spine.<sup><xref ref-type="bibr" rid="bib28">28</xref>,<xref ref-type="bibr" rid="bib29">29</xref></sup> Sham operations were carried out only by detachment of the posterior paravertebral muscles from the L<sub>3</sub>&#x02013;L<sub>5</sub> vertebrae. The operated mice were intraperitoneally injected with either T&#x003b2;RI inhibitor (SB-505124, Sigma-Aldrich, St Louis, MO, USA) at a dose of 1&#x02009;mg&#x000b7;kg<sup>&#x02212;1</sup> (SB group) or the equivalent volume of vehicle (dimethyl sulfoxide; Veh group) once every 2 days. Mice (8-week old) were killed at 0, 1, 2, 4, and 8 weeks after the surgery (<italic>n</italic>=6 per group).</p></sec><sec><title>Caudal spine instability mouse model</title><p>The instability of caudal spine was induced by fully depth annular stab and NP removal of the caudal 7th&#x02013;8th (C<sub>7&#x02013;8</sub>) IVD.<sup><xref ref-type="bibr" rid="bib30">30</xref></sup> The adjacent C<sub>8&#x02013;9</sub> IVDs were chosen for observation at 4 weeks post surgery (<italic>n</italic>=6 per group). The treatments were the same as those described in the first model.</p></sec><sec><title>Rat caudal IVD compression model</title><p>Twelve-week-old male Sprague&#x02013;sDawley rats (Charles River) were attached at caudal vertebrae with a loading device.<sup><xref ref-type="bibr" rid="bib31 bib32 bib33 bib34">31&#x02013;34</xref></sup> In detail, two 0.7366&#x02009;mm stainless steel Kirchner wires were inserted percutaneously into each of the C<sub>8</sub> and C<sub>10</sub>, and attached to 35&#x02009;mm external diameter aluminum rings. Rings were pre-coated with a resin and connected longitudinally with four stainless steel threaded rods. Axial loads were applied by four calibrated springs (0.50&#x02009;N&#x000b7;mm<sup>&#x02212;1</sup>) installed over each rod. In the vehicle (Veh) and 1D11 group, the axial stress loaded from the distal side produced a calculated compressive pressure of 1.3&#x02009;MPa onto C<sub>8&#x02013;9</sub> and C<sub>9&#x02013;10</sub> IVDs through tightening calibrated springs.<sup><xref ref-type="bibr" rid="bib31">31</xref>,<xref ref-type="bibr" rid="bib33">33</xref>,<xref ref-type="bibr" rid="bib34">34</xref></sup> The C<sub>8&#x02013;9</sub> of loaded IVDs was injected with an alginate bead (1&#x02009;&#x003bc;L) containing 0.7&#x02009;&#x003bc;g 1D11 (TGF&#x003b2;-neutralizing antibody; R&#x00026;D Systems, Minneapolis, MN, USA),<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> whereas the C<sub>9&#x02013;10</sub> IVDs with that containing vehicle (<italic>n</italic>=6) once during the surgery. In the sham group, the rats were also attached with the loading device at C<sub>8</sub> and C<sub>10</sub>, but no compressive pressure was exerted onto the IVDs. Both C<sub>8&#x02013;9</sub> and C<sub>9&#x02013;10</sub> were injected with vehicle-containing alginate bead. The rats were killed at 2 weeks after the surgery (<italic>n</italic>=6 per group).</p><p><italic>Noto-cre</italic> (CD1 background mouse expressing Cre recombinase driven by <italic>Noto</italic> promoter) mouse strain was obtained from the lab of Cheryle A. S&#x000e9;guin.<sup><xref ref-type="bibr" rid="bib10">10</xref></sup>
<italic>Tgf&#x003b2;RII</italic><sup><italic>flox/flox</italic></sup> mouse strain (C57BL/6J background mouse homozygous for <italic>Tgf&#x003b2;RII</italic> flox allele) was obtained from the lab of H.L. Moses.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup>
<italic>Noto</italic><sup><italic>cre</italic></sup>::<italic>Tgf&#x003b2;RII</italic><sup><italic>flox/+</italic></sup> mice were generated by crossing heterozygote <italic>Noto-cre</italic> strain with <italic>homozygote Tgf&#x003b2;RII</italic><sup><italic>flox/flox</italic></sup> strain. <italic>Tgf&#x003b2;RII</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> and <italic>Tgf&#x003b2;RI</italic><sup><italic>+/+</italic></sup> (wild-type (WT) littermates) offspring were generated by crossing two <italic>Noto</italic><sup><italic>cre</italic></sup>::<italic>Tgf&#x003b2;RII</italic><sup><italic>flox/+</italic></sup> strains (<italic>Noto</italic><sup><italic>cre</italic></sup>::<italic>Tgf&#x003b2;RII</italic><sup><italic>flox/flox</italic></sup> mice that are <italic>Tgf&#x003b2;RII</italic> conditional deletion in <italic>Noto</italic> lineage cells are referred to as &#x0201c;<italic>Tgf&#x003b2;RII</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>&#x0201d;. <italic>Noto</italic><sup><italic>cre</italic></sup>::<italic>Tgf&#x003b2;RII</italic><sup><italic>+/+</italic></sup> mice that are heterozygous for <italic>Noto-cre</italic> are referred to as &#x0201c;<italic>Tgf&#x003b2;RII</italic><sup><italic>+/+</italic></sup>&#x0201d; in the text, <italic>n</italic>=6 per group).</p><p>The genotype of the mice was determined by PCR analyses of genomic DNA isolated from mouse tails using the following primers: <italic>Noto</italic>-directed <italic>cre</italic> forward, 5&#x02032;-
ATACCGGCAGATCATGCAAGC-3&#x02032;, and reverse, 5&#x02032;-
ATGCACATATGCAACCCACA-3&#x02032;.<sup><xref ref-type="bibr" rid="bib10">10</xref></sup> The <italic>loxP Tgf&#x003b2;RII</italic> allele was identified with the primers forward, 5&#x02032;-
TAAACAAGGTCCGGAGCCCA-3&#x02032;, and reverse, 5&#x02032;-
ACTTCTGCAAGAGGTCCCCT-3&#x02032;.<sup><xref ref-type="bibr" rid="bib36">36</xref></sup></p><p>&#x003b1;<sub><italic>v</italic></sub><sup><italic>flox/flox</italic></sup> mice mouse strain was obtained from the lab of Andrew Burich, Benaroya Research Institute at Virginia Mason. <italic>Noto</italic><sup><italic>cre</italic></sup>::&#x003b1;<sub><italic>v</italic></sub><sup><italic>flox/flox</italic></sup> mice that are &#x003b1;<sub><italic>v</italic></sub> conditional deletion in <italic>Noto</italic> lineage cells are referred to as &#x0201c;&#x003b1;<sub><italic>v</italic></sub><sup><italic>&#x02212;/&#x02212;</italic></sup>&#x0201d;. <italic>Noto</italic><sup><italic>cre</italic></sup>:: &#x003b1;<sub><italic>v</italic></sub><sup><italic>+/+</italic></sup> mice that are heterozygous for <italic>Noto-cre</italic> are referred to as &#x0201c;&#x003b1;<sub><italic>v</italic></sub><sup><italic>+/+</italic></sup>&#x0201d; in the text (<italic>n</italic>=3 per group). The <italic>loxP</italic> &#x003b1;<sub><italic>v</italic></sub> allele was identified with the primers forward, 5&#x02032;-
TTCAGGACGGCACAAAGACCGTTG-3&#x02032;, and reverse, 5&#x02032;-
CACAAATCAAGGATGACCAAACTGAG-3&#x02032;.</p><p>C57BL/6J mice of the following ages: 16.0-day pregnant, 3 days, 1 weeks, 1 month, 2 months, 3 months and 4 months were purchased from Charles River (<italic>n</italic>=6 per time point).</p><p>All animals (rat and mouse) were maintained in the Animal Facility of the Johns Hopkins University School of Medicine. The experimental protocols for both species were reviewed and approved by the Institutional Animal Care and Use Committee of the Johns Hopkins University, Baltimore, MD, USA.</p></sec></sec><sec><title>IVD <italic>ex vivo</italic> compression model</title><p>The L<sub>1</sub>&#x02013;L<sub>5</sub> lumbar IVDs were removed under sterile conditions from 4-week-old C57BL/6J mice. The collected IVDs were organ-cultured in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (Invitrogen, Carlsbad, CA, USA) supplemented with 1% penicillin&#x02013;streptomycin (MediaTech, Dallas, TX, USA) and pretreated with one of the followings: 2&#x02009;ng&#x000b7;mL<sup>&#x02212;1</sup> of recombinant mouse TGF&#x003b2;1 (7666-MB-005, R&#x00026;D, Minneapolis, Minnesota, USA), 5.0&#x02009;&#x003bc;g&#x000b7;ml<sup>&#x02212;1</sup> of 1D11, 2&#x02009;&#x003bc;mol&#x000b7;L<sup>&#x02212;1</sup> of RGD peptide (3498, Tocris Bioscience, Burlington, NC, USA), 100&#x02009;&#x003bc;g&#x000b7;mL<sup>&#x02212;1</sup> of anti-&#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub>-neutralizing antibody (ab77906, Abcam, Cambridge, MA, USA) or Veh (13C4, R&#x00026;D Systems) overnight. Compression loads of 0 or 1.0&#x02009;MPa were applied by vertically placing weights on the IVDs after pretreatment. Loading duration was 24&#x02009;h (<italic>n</italic>=6 per group).<sup><xref ref-type="bibr" rid="bib37">37</xref></sup></p><p>We determined the sample size based on power analysis via website <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.biomath.info">http://www.biomath.info</ext-link> (for two groups, 80% power, 5% significance, two-sided), or via G*Power (for more than two groups, 80% power, 5% significance). For animal model and <italic>Tgf&#x003b2;RII</italic> knockout studies, each experiment was conducted twice: one pilot experiment in three samples and two independent experiments of six samples. For &#x003b1;<sub><italic>v</italic></sub> knockout mice, three independent experiments with six samples were conducted.</p></sec></sec><sec><title>Micro Computed Tomography (&#x003bc;CT)</title><p>The lower thoracic and whole lumbar spine from mice were dissected, fixed in 10% buffered formalin for 48&#x02009;h, transferred into phosphate-buffered saline, and then examined by high-resolution &#x003bc;CT (Skyscan1172). The ribs on the lower thoracic were included for the identification of L<sub>4</sub>&#x02013;L<sub>5</sub> IVD localization. Images were reconstructed and analyzed using NRecon v1.6 and CTAn v1.9 (Skyscan company, San Jose, CA, USA), respectively. Three-dimensional model visualization software, CTVol v2.0 (Skyscan company, San Jose, CA, USA), was used to analyze parameters of the L<sub>4</sub>&#x02013;L<sub>5</sub> IVD with half height of L<sub>4</sub> and L<sub>5</sub> vertebrae. The scanner was set at a voltage of 49&#x02009;kVp, a current of 200&#x02009;&#x003bc;A, and a resolution of 6.8&#x02009;&#x003bc;m per pixel to measure the IVD and endplate (EP). A resolution 16.8&#x02009;&#x003bc;m of per pixel was set for the whole L<sub>5</sub> vertebral body measurement. Coronal images of the L<sub>4</sub>&#x02013;L<sub>5</sub> IVD were used to perform three-dimensional histomorphometric analyses of IVD. IVD volume was defined by the region of interest to cover the whole invisible space between L<sub>4</sub> and L<sub>5</sub> vertebrae. Parameter: TV (total tissue volume) was used for three-dimensional structural analysis.</p></sec><sec><title>Histochemistry, immunohistochemistry, and histomorphometry</title><p>The specimens were fixed in 10% buffered formalin for 48&#x02009;h, decalcified in 10% EDTA (pH 7.4) for 14 days, dehydrated, and embedded in paraffin. Four-micrometer-thick coronal-oriented sections of the L<sub>4</sub>&#x02013;L<sub>5</sub>, C<sub>7&#x02013;9</sub>, or C<sub>8&#x02013;10</sub> spine were processed for safranin O and fast green staining. Tartrate-resistant acid phosphatase staining was performed using a standard protocol (Sigma-Aldrich). Immunostaining was performed using a standard protocol. Sections were incubated with primary antibodies to mouse aggrecan (1:200, AB1031, Millipore, Billerica, MA, USA), CCN2 (1:400, ab6992, Abcam), pSmad2/3 (1:200, sc-11769, Santa Cruz, Dallas, TX, USA), integrin &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> (1:100, bs-5791R-Biotin, Bioss, Woburn, MA, USA), integrin &#x003b1;<sub>V</sub>&#x003b2;<sub>3</sub> (1:100, bs-1310R, Bioss), integrin &#x003b1;<sub>V</sub>&#x003b2;<sub>5</sub> (1:100, bs-1356R, Bioss), integrin &#x003b2;<sub>8</sub> (1:300, ab80673, Abcam), integrin &#x003b1;<sub>V</sub> (Santa Cruz, 1:100, sc-6617-R), integrin &#x003b2;<sub>6</sub> (Santa Cruz, 1:100, sc-6632), and TGF&#x003b2;RII (1:100, sc-400, Santa Cruz) at 4&#x02009;&#x000b0;C overnight. For immunohistochemical staining, a horseradish peroxidase-streptavidin detection system (Dako, Carpinteria, CA, USA) was subsequently used to detect the immunoactivity, followed by counterstaining with hematoxylin (Sigma-Aldrich). For immunofluorescent assay, the slides were incubated with secondary antibodies conjugated with fluorescence at room temperature for 1&#x02009;h while avoiding light. Morphometric study was performed by an image autoanalysis system (Olympus DP71, SEG Biological Microscopes, Center Valley, Pennsylvania, USA). Triplicates of each sample were used for staining.</p></sec><sec><title>Quantitative histomorphometric analysis</title><p>Quantitative histomorphometric analysis was conducted in a blinded manner with Image-Pro Plus Software version 6.0 (Media Cybernetics Inc, Rockville, Maryland, USA). EP and IVD scores were obtained as previously described.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib38">38</xref></sup> The percentage of pSmad2/3-positive cells was obtained by counting the number of positive staining cells to the number of total cells in the NP region. The expression of integrin &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> was calculated by the sum of integrated optical density in the NP region. The area of CCN2-positive staining was calculated in the whole L<sub>4</sub>&#x02013;L<sub>5</sub> IVD in lumbar spine instability (LSI) mice (2-month old). In other experiments, the area of CCN2-positive staining was calculated only in the NP region. The percentage of Acan-positive staining was calculated by counting the positive staining area of region of interest that covers all cells in NP.</p></sec><sec><title>Quantitative reverse transcription-PCR</title><p>Total RNA was extracted from NP tissue of IVD in <italic>ex vivo</italic> assay using TRIzol reagent (Sigma-Aldrich) according to the manufacturer&#x02019;s instruction. The yield and purity of RNA were estimated spectrophotometrically using theA260/A280 ratio. Two micrograms of RNA was reverse-transcribed into complementary DNA using the SuperScript first-strand synthesis system (Invitrogen). One microliter of complementary DNA was subjected to quantitative reverse transcription-PCR amplification using SYBR GREENPCR Master Mix (Promega, Madison, WI, USA) and sequence-specific primers for Acan: 5&#x02032;-
CAGATGGCACCCTCCGATAC-3&#x02032;and 5&#x02032;-
GACACACCTCGGAAGCAGAA-3&#x02032;. The value of gene expression was normalized relative to the mouse GAPDH: 5&#x02032;-
AATGTGTCCGTCGTGGATCTGA-3&#x02032; and 5&#x02032;-
AGTGTAGCCCAAGATGCCCTTC-3&#x02032;. PCR reactions were performed in triplicates. The data were analyzed using the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method.</p></sec><sec><title>Western blot</title><p>Western blot analyses were conducted on the protein extraction from NP tissue in <italic>ex vivo</italic> assay. The protein extraction was centrifuged, and the concentration of supernatants was evaluated by DC protein assay (Bio-Rad Laboratories, Hercules, CA, USA), then the proteins were separated by SDS-polyacrylamide gel electrophoresis and blotted on a polyvinylidene fluoride membrane (Bio-Rad Laboratories). After incubation in specific antibodies, proteins were detected using an enhanced chemiluminescence kit (Amersham Biosciences, Pittsburgh, PA, USA). The target protein concentrations were examined by antibodies recognizing mouse pSmad2 (1:1&#x02009;000, 3101, Cell Signaling Technology Inc., Danvers, MA, USA), Smad2 (1:1&#x02009;000, 3103, Cell Signaling Technology Inc.), integrin &#x003b1;<sub>V</sub> (1:500, sc-6617-R, Santa Cruz), and GAPDH (1:1&#x02009;000, 8884, Cell Signaling Technology Inc.).</p></sec><sec><title>Statistics</title><p>The data were expressed as mean&#x000b1;s.d., and statistical significance was determined using a Student&#x02019;s <italic>t</italic>-test in time point or genetic mice comparison, or one-way analysis of variance followed by a <italic>post hoc</italic> Least-Significance-Difference (LSD) test (homogeneity of variance) or a Tukey&#x02019;s test (heterogeneity of variance) in treatment or <italic>ex vivo</italic> assay comparison. The level of significance was defined as <italic>P</italic>&#x0003c;0.05. All data analyses were performed using SPSS 15.0 analysis software (SPSS Inc, Chicago, Illinois, USA).</p></sec></sec><sec><title>Results</title><sec><title>Activation of TGF&#x003b2; associates with reduced NC cell vacuoles and increased extracellular proteoglycan in response to mechanical stress</title><p>The IVD height increased in mice from birth through 1 month, and then remained stable before decreasing around 4 months. The NC cells&#x02019; sphere-shaped vacuole observed at birth changed to a spindle-like shape by 4 months (<xref ref-type="fig" rid="fig1">Figure 1a and c</xref>). Extracellular aggrecan secretion was stimulated on day 3 after birth and accumulated around the NC cells to generate IVD extracellular space adjacent to endplates from day 7 (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). To investigate that these changes were associated with mechanical stress, we employed a LSI mouse model by removing spinous processes and posterior supraspinous and interspinous ligaments (<xref ref-type="fig" rid="fig1">Figure 1d</xref>).<sup><xref ref-type="bibr" rid="bib28">28</xref>,<xref ref-type="bibr" rid="bib29">29</xref></sup> The effects of mechanical stress on NC cells were analyzed by immunostaining of the IVD sections collected from 2-month-old LSI mice, in which the IVD space is peaked. The vacuole sizes of NC cells gradually decreased beginning at 2 weeks post surgery in LSI, whereas in the sham-operated mice NC size decreased at 4 weeks with Safranin O staining (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Significant IVD degeneration was observed in LSI mice relative to sham-operated mice, as shown by IVD score beginning as early as 1 week post surgery<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib38">38</xref></sup> (<xref ref-type="fig" rid="fig1">Figure 1g</xref>). Mechanical stress has been shown to activate latent TGF&#x003b2;.<sup><xref ref-type="bibr" rid="bib20">20</xref>,<xref ref-type="bibr" rid="bib21">21</xref>,<xref ref-type="bibr" rid="bib39">39</xref>,<xref ref-type="bibr" rid="bib40">40</xref></sup> Immunostaining revealed that phosphorylated Smad2/3-positive cells (pSmad2/3<sup>+</sup>) in the NP were significantly increased 1, 2, and 4 weeks post surgery in the LSI mice relative to the sham controls (<xref ref-type="fig" rid="fig1">Figure 1f and h</xref>). Further, the levels of CCN2, a TGF&#x003b2; downstream factor that upregulates the synthesis of matrix proteins in IVDs,<sup><xref ref-type="bibr" rid="bib26">26</xref>,<xref ref-type="bibr" rid="bib27">27</xref>,<xref ref-type="bibr" rid="bib41 bib42 bib43">41&#x02013;43</xref></sup> were significantly increased 2 weeks post surgery in LSI mice and gradually decreased to sham control levels by 4 weeks, consistent with the increase of TGF&#x003b2; activity (<xref ref-type="fig" rid="fig2">Figure 2a&#x02013;c</xref>). Similarly, aggrecan expression, upregulated by CCN2,<sup><xref ref-type="bibr" rid="bib26">26</xref>,<xref ref-type="bibr" rid="bib44">44</xref></sup> was also increased in LSI mice (<xref ref-type="fig" rid="fig2">Figure 2d and e</xref>). Taken together, the data reveal that increase of TGF&#x003b2; activity in response to mechanical stress stimulates secretion of extracellular proteins such as aggrecan. Simultaneously, a reduction in intracellular vacuoles was observed with a transition of IVD space maintained by intracellular vacuoles in early postnatal life versus extracellular matrix in adulthood or with increased mechanical stress.</p></sec><sec><title>Integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> induces TGF&#x003b2; activation in response to mechanical stress to regulate NC cell function</title><p>We then investigated the mechanism of mechanical stress-induced activation of latent TGF&#x003b2;. The &#x003b1;<sub>v</sub>&#x003b2; integrins are one known mechanism that mediates cell-induced conformational change of TGF&#x003b2; latent complex to release active TGF&#x003b2;.<sup><xref ref-type="bibr" rid="bib21 bib22 bib23 bib24">21&#x02013;24</xref>,<xref ref-type="bibr" rid="bib45">45</xref>,<xref ref-type="bibr" rid="bib46">46</xref></sup> The &#x003b1;<sub>v</sub> integrin is the common &#x003b1; subunit for &#x003b2; integrins. Immunostaining of IVD sections revealed that the expression of one specific &#x003b2; integrin, &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>, in the NP was significantly increased 2 and 4 weeks post surgery in LSI mice relative to sham control (<xref ref-type="fig" rid="fig3">Figure 3a and b</xref>). The pattern of elevation of &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> expression was similar to the increase of pSmad2/3-positive cells (<xref ref-type="fig" rid="fig1">Figure 1f and h</xref>), whereas the expression of &#x003b2;<sub>8</sub>, &#x003b1;<sub>v</sub>&#x003b2;<sub>5</sub>, and &#x003b1;<sub>v</sub>&#x003b2;<sub>3</sub> did not correlate (<xref ref-type="fig" rid="fig3">Figure 3c&#x02013;h</xref>).</p><p>To determine a causal relationship, active TGF&#x003b2;, RGD peptide, neutralizing antibodies against TGF&#x003b2; or&#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>, or vehicle were applied to an <italic>ex vivo</italic> IVD compression loading model.<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> Immunostaining demonstrated that RGD peptide, antibodies against TGF&#x003b2; (1D11), or &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> all inhibited stress-induced phosphorylation of Smad2/3 in NC cells (<xref ref-type="fig" rid="fig3">Figure 3i and k</xref>). The result was confirmed by western blot analysis (<xref ref-type="fig" rid="fig3">Figure 3l</xref>). Importantly, the morphology of NC cell vacuoles was altered in the active TGF&#x003b2; and vehicle-compression treatment groups (<xref ref-type="fig" rid="fig3">Figure 3j</xref>, second and third row), whereas the sphere shape of vacuoles was maintained in the RGD, TGF&#x003b2; (1D11), and &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> antibody groups (<xref ref-type="fig" rid="fig3">Figure 3j</xref>, bottom three rows) relative to the zero compression vehicle group (<xref ref-type="fig" rid="fig3">Figure 3j</xref>, top row). In contrast, the extracellular CCN2 and aggrecan were significantly stimulated in the active TGF&#x003b2; group and compression group treated with vehicle (<xref ref-type="fig" rid="fig4">Figure 4a and b</xref>, rows 2 and 3; <xref ref-type="fig" rid="fig4">Figure 4c and d</xref>) but inhibited in the RGD and TGF&#x003b2; antibody groups (<xref ref-type="fig" rid="fig4">Figure 4a and b</xref>, rows 4 and 5). Messenger RNA expression of aggrecan was similarly inhibited by RGD and TGF&#x003b2; antibody (<xref ref-type="fig" rid="fig4">Figure 4e</xref>).</p></sec><sec><title>Conditional knockout of TGF&#x003b2; type II receptor prohibits functional transition of NC cells</title><p>To confirm the role of TGF&#x003b2; in control of NC cell function <italic>in vivo</italic>, notochord-originated cell-specific <italic>TgfbrII</italic> knockout mice (<italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup>) were generated by crossing floxed <italic>TgfbrII</italic> mice with <italic>Noto-Cre</italic> mice. T&#x003b2;RII<italic>-</italic> and pSmad2/3-positive NC cells were almost undetectable in immunostaining of IVD sections of <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5a&#x02013;d</xref>), validating our mouse model. Immunostaining demonstrated that CCN2 and aggrecan were much lower in the NPs of <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice relative to WT <italic>TgfbrII</italic><sup>+/+</sup> littermates (<xref ref-type="fig" rid="fig5">Figure 5e&#x02013;h</xref>), further confirming CCN2 and aggrecan as downstream signaling targets. Safranin O staining of IVD sections showed that NC cells have much larger vacuoles with less proteoglycan in 4-week-old <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice relative to their WT <italic>TgfbrII</italic><sup>+/+</sup> littermates (<xref ref-type="fig" rid="fig5">Figure 5i</xref>). Furthermore, the IVD volume was significantly increased in the <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice in comparison to their WT <italic>TgfbrII</italic><sup>+/+</sup> littermates in &#x003bc;CT analysis (<xref ref-type="fig" rid="fig5">Figure 5j</xref>). These genetic data demonstrate that TGF&#x003b2; signaling in NC cells affects vacuole size for IVD morphology.</p></sec><sec><title>Conditional knockout of integrin &#x003b1;<sub>v</sub> impedes postnatal functional transition of NC cells</title><p>We then examined the role of integrin &#x003b1;<sub>v</sub> in activation of TGF&#x003b2; in notochord cells as &#x003b1;<sub>v</sub> chain is the core to mediate the activation of TGF&#x003b2;. Floxed &#x003b1;<sub><italic>v</italic></sub> mice were crossed with <italic>Noto-Cre</italic> mice to generate &#x003b1;<sub><italic>v</italic></sub> knockout mice (&#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup>). Immunostaining of IVD sections validated that &#x003b1;<sub>v</sub> expression was diminished specifically in NC cells, whereas the expression remained unchanged in AF and EP cells in &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup>mice relative to their WT &#x003b1;<sub><italic>v</italic></sub><sup>+/+</sup> littermates (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Integrin &#x003b2;<sub>6</sub> expression was unaffected in the &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> NC cells (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). The reduction of &#x003b1;<sub>v</sub> in the &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> NC cells was further confirmed by western blot analysis (<xref ref-type="fig" rid="fig6">Figure 6k</xref>). As expected, &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>- and pSmad2/3-positive NC cells were significantly reduced in &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup>mice relative to WT &#x003b1;<sub><italic>v</italic></sub><sup>+/+</sup> littermates (<xref ref-type="fig" rid="fig6">Figure 6c, d, g and h</xref>). The contents of CCN2 and aggrecan were also much lower in the NPs of &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> mice relative to WT &#x003b1;<sub><italic>v</italic></sub><sup>+/+</sup> littermates (<xref ref-type="fig" rid="fig6">Figure 6e, f, i and j</xref>). Similar to <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup>mice, NC cells had much larger vacuoles with less proteoglycan in the &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> mice relative to their WT littermates (<xref ref-type="fig" rid="fig6">Figure 6m</xref>). The &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> and <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice demonstrate that disruption of TGF&#x003b2; signaling can delay NC morphologic transition. Therefore, to evaluate whether the morphologic change of vacuoles was sufficient to prevent mechanically induced IVD degeneration, we further subjected &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> and <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice to LSI or sham surgery (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). Safranin O staining showed that IVD was significantly degenerated in both LSI &#x003b1;<sub><italic>v</italic></sub><sup>&#x02212;/&#x02212;</sup> and <italic>TgfbrII</italic><sup>&#x02212;/&#x02212;</sup> mice relative their sham-operated controls (<xref ref-type="fig" rid="fig6">Figure 6n</xref>), and demonstrated that complete loss of NC cell TGF&#x003b2; signaling can also be as detrimental as excessive TGF&#x003b2; signaling.</p></sec><sec><title>Inhibition of excess activation of TGF&#x003b2; attenuates IVD degeneration</title><p>We examined whether inhibition of excessive active TGF&#x003b2; is beneficial for IVD degeneration. TGF&#x003b2; type I receptor (T&#x003b2;RI) inhibitor (1&#x02009;mg&#x000b7;kg<sup>&#x02212;1</sup>) was intraperitoneally injected in the LSI mice post surgery. Degeneration of IVD was attenuated as assessed by IVD score (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). The vacuolar morphology was preserved with the T&#x003b2;RI inhibitor treatment relative to sham-operated versus LSI-operated with vehicle treatment (<xref ref-type="fig" rid="fig7">Figure 7d</xref>). As expected, pSmad2/3<sup>+</sup> cells were reduced by T&#x003b2;RI inhibitor (<xref ref-type="fig" rid="fig7">Figure 7b and e</xref>). Expression of aggrecan and CCN2 was maintained at similar levels of sham-operated mice as opposed to the elevation of both seen in the LSI-operated vehicle-treated group (<xref ref-type="fig" rid="fig7">Figure 7c, f and g</xref>).</p><p>In parallel, we administrated the TGF&#x003b2;-neutralizing antibody directly into the IVD in a rat caudal IVD compression model.<sup><xref ref-type="bibr" rid="bib31 bib32 bib33 bib34">31&#x02013;34</xref></sup> (<xref ref-type="fig" rid="fig8">Figure 8a</xref>) Neutralizing active TGF&#x003b2; in the IVD prevented IVD degeneration as defined by preservation of the NC cells morphology under static compression relative to vehicle treatment (<xref ref-type="fig" rid="fig8">Figure 8c</xref>). The expression pSmad2/3<sup>+</sup> in the NC cells was reduced with TGF&#x003b2; antibody treatment compared to vehicle under static compression (<xref ref-type="fig" rid="fig8">Figure 8d and h</xref>). Similar results were obtained using a caudal spine instability mouse model by intraperitoneal injection of T&#x003b2;RI inhibitor<sup><xref ref-type="bibr" rid="bib30">30</xref>,<xref ref-type="bibr" rid="bib47">47</xref>,<xref ref-type="bibr" rid="bib48">48</xref></sup> (<xref ref-type="fig" rid="fig8">Figure 8b</xref>), in which IVD degeneration was effectively prevented (<xref ref-type="fig" rid="fig8">Figure 8e&#x02013;g</xref> and <xref ref-type="fig" rid="fig8">8i&#x02013;k</xref> ).</p></sec></sec><sec><title>Discussion</title><p>The initiation of DDD by NP dysfunction is a hot topic in the spinal disease field. NP cells originate from the notochord. During development, NC cells regulate the spinal morphogenesis by control of intracellular vacuoles evenly distributed in the NP to generate intervertebral space.<sup><xref ref-type="bibr" rid="bib6">6</xref>,<xref ref-type="bibr" rid="bib10">10</xref>,<xref ref-type="bibr" rid="bib49">49</xref>,<xref ref-type="bibr" rid="bib50">50</xref></sup> After birth, IVDs gradually change their content with a reduction of intracellular vacuoles of NC cells corresponding to increase extracellular proteoglycans.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> Loss of vacuolar NC cells and their morphologic and functional transition are thought as early degenerative changes of IVD.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> However, the mechanism of NC cells transition is not well understood. In this study, we revealed that integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>-induced activation of TGF&#x003b2; controls the functional transition of NC cells in IVDs in multiple rodent models. Active TGF&#x003b2; reduced intracellular vacuoles of NC cells, but increased extracellular proteoglycans, thereby shifting the burden of mechanical loads from the cells to the extracellular environment.</p><p>Mechanical loads are one of the most important etiologies of DDD.<sup><xref ref-type="bibr" rid="bib50">50</xref></sup> In normal physiological situations, appropriate mechanical loading produced by body weight and muscle force is necessary to activate TGF&#x003b2; in the NP to modulate anabolic activity of NC cells and maintain IVD homeostasis, similar to its role in homeostasis of the bone and cartilage.<sup><xref ref-type="bibr" rid="bib40">40</xref>,<xref ref-type="bibr" rid="bib51 bib52 bib53">51&#x02013;53</xref></sup> However, in pathological conditions, as we found in the present study, compression stresses activate excess TGF&#x003b2; and result in accelerated functional transition of NC cells, leading to pathologic changes of IVD.</p><p>Central to this mechanosignal transduction is the activation of TGF&#x003b2; by integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub>. Several of integrin &#x003b1; and &#x003b2; chains have been found in IVD involving in cell&#x02013;matrix interaction.<sup><xref ref-type="bibr" rid="bib25">25</xref>,<xref ref-type="bibr" rid="bib54">54</xref></sup> Integrin &#x003b1;<sub>5</sub>&#x003b2;<sub>1</sub> has recently been shown to be associated with mechanotransduction in IVD cells.<sup><xref ref-type="bibr" rid="bib55">55</xref></sup> Mechanical stress has been shown to induce cell cytoskeleton changes, leading to integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> binding to the latent TGF&#x003b2; complex for its conformational change to allow active TGF&#x003b2; to bind to its receptor.<sup><xref ref-type="bibr" rid="bib45">45</xref></sup> Similarly, we found it is integrin &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> that correlates to active TGF&#x003b2; signaling pathway and regulates NC cells function by mechanical stimili. TGF&#x003b2; signaling activates transcription and secretion of CCN2, which in turn binds to CCN2 receptor to stimulate a cascade of changes in extracellular proteoglycan expression.<sup><xref ref-type="bibr" rid="bib56">56</xref></sup> Aggrecan, the major proteoglycan in IVD, exerts osmotic pressure to resist compressive loads.<sup><xref ref-type="bibr" rid="bib57">57</xref></sup> However, aggrecan also affects the osmotic pressure in the IVD. Besides shifting water from outside the IVD, our study suggests that aggrecan likely also results in a shifting of water from intracellular to extracelluar matrix and leads to NC cells morphologic transition by dehydration.</p><p>TGF&#x003b2; is recognized as an anabolic factor in IVD and has been found to prevent DDD.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> However, high levels of TGF&#x003b2;1 have also been observed in the IVDs from DDD patients.<sup><xref ref-type="bibr" rid="bib39">39</xref>,<xref ref-type="bibr" rid="bib40">40</xref>,<xref ref-type="bibr" rid="bib59 bib60 bib61 bib62 bib63">59&#x02013;63</xref></sup> One group has previously shown that inhibition of TGF&#x003b2; can prevent DDD, which was attributed to a change in pSmad1/5/8 to pSmad 2/3 downstream signaling.<sup><xref ref-type="bibr" rid="bib64">64</xref></sup> The various effects of TGF&#x003b2; are likely related to the concentration of TGF&#x003b2;. Our results demonstrated that pathologic mechanical loading on the spine drove aberrant overactivation of TGF&#x003b2;, resulting in DDD. Complete inhibition of TGF&#x003b2; signaling in knockout of T&#x003b2;RII or &#x003b1;<sub>v</sub> mice also caused IVD degeneration by mechanical stimuli. Thus, TGF&#x003b2; regulates IVD cell function and homeostasis, whereas either high or low concentrations of TGF&#x003b2; led to DDD development.</p><p>DDD is a polygenic disease exacerbated by many different factors.<sup><xref ref-type="bibr" rid="bib2">2</xref>,<xref ref-type="bibr" rid="bib16">16</xref>,<xref ref-type="bibr" rid="bib50">50</xref>,<xref ref-type="bibr" rid="bib64 bib65 bib66 bib67 bib68">64&#x02013;68</xref></sup> In this study, we found that under mechanical stress, &#x003b1;v&#x003b2;6 integrin is activated and can release TGF&#x003b2; from its latent form. Activation of TGF&#x003b2; signaling pathway in multiple mouse models increased the expression of CCN2, which then upregulated aggrecan. High levels of aggrecan likely increase the osmotic pressure of the extracellular environment to result in a shift in vacuole liquid volume, resulting in an apparent change in NC cell morphology, from vacuole-like to fibroblast-like cells (<xref ref-type="fig" rid="fig8">Figure 8l</xref>). Reduction of aberrant TGF&#x003b2; overactivation in the IVDs through modulation of mechanical stress, or inhibition of either &#x003b1;<sub>v</sub>&#x003b2;<sub>6</sub> or TGF&#x003b2; signaling, could have therapeutic potential for DDD.</p></sec></body><back><ack><p>We thank the following colleagues for their technical support: Xin Xu, Wenlong Liu, Gehua Zhen, Shouan Zhu, Xiaokai Wang, Changjun Li, Hui Xie and Liang Xie.</p></ack><fn-group><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></fn-group><ref-list><ref id="bib1"><mixed-citation publication-type="journal">Boos N, Weissbach S, Rohrbach H et al. <article-title>Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science</article-title>. <source>Spine</source>
<year>2002</year>; <volume>27</volume>: <fpage>2631</fpage>&#x02013;2644.<pub-id pub-id-type="pmid">12461389</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">Miller JA, Schmatz C, Schultz AB. <article-title>Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens</article-title>. <source>Spine</source>
<year>1988</year>; <volume>13</volume>: <fpage>173</fpage>&#x02013;178.<pub-id pub-id-type="pmid">3406837</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">Raj PP. <article-title>Intervertebral disc: anatomy-physiology-pathophysiology-treatment</article-title>. <source>Pain Pract</source>
<year>2008</year>; <volume>8</volume>: <fpage>18</fpage>&#x02013;44.<pub-id pub-id-type="pmid">18211591</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">Chou R, Huffman LH. <article-title>Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline</article-title>. <source>Ann Intern Med</source>
<year>2007</year>; <volume>147</volume>: <fpage>505</fpage>&#x02013;514.<pub-id pub-id-type="pmid">17909211</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">Levin DA, Bendo JA, Quirno M et al. <article-title>Comparative charge analysis of one- and two-level lumbar total disc arthroplasty versus circumferential lumbar fusion</article-title>. <source>Spine</source>
<year>2007</year>; <volume>32</volume>: <fpage>2905</fpage>&#x02013;2909.<pub-id pub-id-type="pmid">18246016</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">Aguiar DJ, Johnson SL, Oegema TR. <article-title>Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis</article-title>. <source>Exp Cell Res</source>
<year>1999</year>; <volume>246</volume>: <fpage>129</fpage>&#x02013;137.<pub-id pub-id-type="pmid">9882522</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">Hunter CJ, Matyas JR, Duncan NA. <article-title>Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison</article-title>. <source>J Anat</source>
<year>2004</year>; <volume>205</volume>: <fpage>357</fpage>&#x02013;262.<pub-id pub-id-type="pmid">15575884</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">Hunter CJ, Matyas JR, Duncan NA. <article-title>The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering</article-title>. <source>Tissue Eng</source>
<year>2003</year>; <volume>9</volume>: <fpage>667</fpage>&#x02013;677.<pub-id pub-id-type="pmid">13678445</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">Risbud MV, Schaer TP, Shapiro IM. <article-title>Toward an understanding of the role of notochordal cells in the adult intervertebral disc: from discord to accord</article-title>. <source>Dev Dyn</source>
<year>2010</year>; <volume>239</volume>: <fpage>2141</fpage>&#x02013;2148.<pub-id pub-id-type="pmid">20568241</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">McCann MR, Tamplin OJ, Rossant J et al. <article-title>Tracing notochord-derived cells using a Noto-cre mouse: implications for intervertebral disc development</article-title>. <source>Dis Model Mech</source>
<year>2012</year>; <volume>5</volume>: <fpage>73</fpage>&#x02013;82.<pub-id pub-id-type="pmid">22028328</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">Sivakamasundari V, Lufkin T. <article-title>Bridging the gap: understanding embryonic intervertebral disc development</article-title>. <source>Cell Dev Biol</source>
<year>2012</year>; <volume>1</volume>: pii: 103.</mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">Ellis K, Hoffman BD, Bagnat M. <article-title>The vacuole within: how cellular organization dictates notochord function</article-title>. <source>Bioarchitecture</source>
<year>2013</year>; <volume>3</volume>: <fpage>64</fpage>&#x02013;68.<pub-id pub-id-type="pmid">23887209</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">Choi KS, Harfe BD. <article-title>Hedgehog signaling is required for formation of the notochord sheath and patterning of nuclei pulposi within the intervertebral discs</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2011</year>; <volume>108</volume>: <fpage>9484</fpage>&#x02013;9489.<pub-id pub-id-type="pmid">21606373</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">Dahia CL, Mahoney E, Wylie C. <article-title>Shh signaling from the nucleus pulposus is required for the postnatal growth and differentiation of the mouse intervertebral disc</article-title>. <source>PLoS ONE</source>
<year>2012</year>; <volume>7</volume>: <fpage>e35944</fpage>.<pub-id pub-id-type="pmid">22558278</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">Leung VY, Chan WC, Hung SC et al. <article-title>Matrix remodeling during intervertebral disc growth and degeneration detected by multichromatic FAST staining</article-title>. <source>J Histochem Cytochem</source>
<year>2009</year>; <volume>57</volume>: <fpage>249</fpage>&#x02013;256.<pub-id pub-id-type="pmid">19001641</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">Adams MA, Roughley PJ. <article-title>What is intervertebral disc degeneration, and what causes it?</article-title>
<source>Spine</source>
<year>2006</year>; <volume>31</volume>: <fpage>2151</fpage>&#x02013;2161.<pub-id pub-id-type="pmid">16915105</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">Setton LA, Chen J. <article-title>Mechanobiology of the intervertebral disc and relevance to disc degeneration</article-title>. <source>J Bone Joint Surg Am</source>
<year>2006</year>; <volume>88 Suppl 2</volume>: <fpage>52</fpage>&#x02013;57.<pub-id pub-id-type="pmid">16595444</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">Zhen G, Wen C, Jia X et al. <article-title>Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis</article-title>. <source>Nat Med</source>
<year>2013</year>; <volume>19</volume>: <fpage>704</fpage>&#x02013;712.<pub-id pub-id-type="pmid">23685840</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">Wipff PJ, Rifkin DB, Meister JJ et al. <article-title>Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix</article-title>. <source>J Cell Biol</source>
<year>2007</year>; <volume>179</volume>: <fpage>1311</fpage>&#x02013;1323.<pub-id pub-id-type="pmid">18086923</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">Henderson NC, Arnold TD, Katamura Y et al. <article-title>Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs</article-title>. <source>Nat Med</source>
<year>2013</year>; <volume>19</volume>: <fpage>1617</fpage>&#x02013;1624.<pub-id pub-id-type="pmid">24216753</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">Mamuya FA, Duncan MK. <article-title>aV integrins and TGF-beta-induced EMT: a circle of regulation</article-title>. <source>J Cell Mol Med</source>
<year>2012</year>; <volume>16</volume>: <fpage>445</fpage>&#x02013;455.<pub-id pub-id-type="pmid">21883891</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">Worthington JJ, Klementowicz JE, Travis MA. <article-title>TGFbeta: a sleeping giant awoken by integrins</article-title>. <source>Trends Biochem Sci</source>
<year>2011</year>; <volume>36</volume>: <fpage>47</fpage>&#x02013;54.<pub-id pub-id-type="pmid">20870411</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">Sheppard D. <article-title>Integrin-mediated activation of latent transforming growth factor beta</article-title>. <source>Cancer Metastasis Rev</source>
<year>2005</year>; <volume>24</volume>: <fpage>395</fpage>&#x02013;402.<pub-id pub-id-type="pmid">16258727</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">Munger JS, Huang X, Kawakatsu H et al. <article-title>The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis</article-title>. <source>Cell</source>
<year>1999</year>; <volume>96</volume>: <fpage>319</fpage>&#x02013;328.<pub-id pub-id-type="pmid">10025398</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">Nettles DL, Richardson WJ, Setton LA. <article-title>Integrin expression in cells of the intervertebral disc</article-title>. <source>J Anat</source>
<year>2004</year>; <volume>204</volume>: <fpage>515</fpage>&#x02013;520.<pub-id pub-id-type="pmid">15198692</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">Tran CM, Markova D, Smith HE et al. <article-title>Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling</article-title>. <source>Arthritis Rheum</source>
<year>2010</year>; <volume>62</volume>: <fpage>1983</fpage>&#x02013;1992.<pub-id pub-id-type="pmid">20222112</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">Bedore J, Sha W, McCann MR et al. <article-title>Impaired intervertebral disc development and premature disc degeneration in mice with notochord-specific deletion of CCN2</article-title>. <source>Arthritis Rheum</source>
<year>2013</year>; <volume>65</volume>: <fpage>2634</fpage>&#x02013;2644.<pub-id pub-id-type="pmid">23839921</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">Miyamoto S, Yonenobu K, Ono K. <article-title>Experimental cervical spondylosis in the mouse</article-title>. <source>Spine</source>
<year>1991</year>; <volume>16</volume> (10 Suppl): <fpage>S495</fpage>&#x02013;S500.<pub-id pub-id-type="pmid">1801260</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">Ariga K, Miyamoto S, Nakase T et al. <article-title>The relationship between apoptosis of endplate chondrocytes and aging and degeneration of the intervertebral disc</article-title>. <source>Spine</source>
<year>2001</year>; <volume>26</volume>: <fpage>2414</fpage>&#x02013;2420.<pub-id pub-id-type="pmid">11707702</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">Rousseau MA, Ulrich JA, Bass EC et al. <article-title>Stab incision for inducing intervertebral disc degeneration in the rat</article-title>. <source>Spine</source>
<year>2007</year>; <volume>32</volume>: <fpage>17</fpage>&#x02013;24.<pub-id pub-id-type="pmid">17202887</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">Lotz JC, Chin JR. <article-title>Intervertebral disc cell death is dependent on the magnitude and duration of spinal loading</article-title>. <source>Spine</source>
<year>2000</year>; <volume>25</volume>: <fpage>1477</fpage>&#x02013;1483.<pub-id pub-id-type="pmid">10851095</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">Lotz JC, Colliou OK, Chin JR et al. <article-title>Compression-induced degeneration of the intervertebral disc: an in vivo mouse model and finite-element study</article-title>. <source>Spine</source>
<year>1998</year>; <volume>23</volume>: <fpage>2493</fpage>&#x02013;2506.<pub-id pub-id-type="pmid">9854748</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">Walsh AJ, Lotz JC. <article-title>Biological response of the intervertebral disc to dynamic loading</article-title>. <source>J Biomech</source>
<year>2004</year>; <volume>37</volume>: <fpage>329</fpage>&#x02013;337.<pub-id pub-id-type="pmid">14757452</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">Yurube T, Nishida K, Suzuki T et al. <article-title>Matrix metalloproteinase (MMP)-3 gene up-regulation in a rat tail compression loading-induced disc degeneration model</article-title>. <source>J Orthop Res</source>
<year>2010</year>; <volume>28</volume>: <fpage>1026</fpage>&#x02013;1032.<pub-id pub-id-type="pmid">20162718</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">Chytil A, Magnuson MA, Wright CV et al. <article-title>Conditional inactivation of the TGF-beta type II receptor using Cre:Lox</article-title>. <source>Genesis</source>
<year>2002</year>; <volume>32</volume>: <fpage>73</fpage>&#x02013;75.<pub-id pub-id-type="pmid">11857781</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">Qiu T, Wu X, Zhang F et al. <article-title>TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling</article-title>. <source>Nat Cell Biol</source>
<year>2010</year>; <volume>12</volume>: <fpage>224</fpage>&#x02013;234.<pub-id pub-id-type="pmid">20139972</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">Ariga K, Yonenobu K, Nakase T et al. <article-title>Mechanical stress-induced apoptosis of endplate chondrocytes in organ-cultured mouse intervertebral discs: an ex vivo study</article-title>. <source>Spine</source>
<year>2003</year>; <volume>28</volume>: <fpage>1528</fpage>&#x02013;1533.<pub-id pub-id-type="pmid">12865839</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">Masuda K, Aota Y, Muehleman C et al. <article-title>A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration</article-title>. <source>Spine</source>
<year>2005</year>; <volume>30</volume>: <fpage>5</fpage>&#x02013;14.<pub-id pub-id-type="pmid">15626974</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">Yang Y, He X, Li Y et al. <article-title>[Association of transforming growth factor-beta1 with pathological grading of intervertebral disc degeneration]</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source>
<year>2012</year>; <volume>32</volume>: <fpage>897</fpage>&#x02013;900.<pub-id pub-id-type="pmid">22699080</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">Peng B, Hao J, Hou S et al. <article-title>Possible pathogenesis of painful intervertebral disc degeneration</article-title>. <source>Spine</source>
<year>2006</year>; <volume>31</volume>: <fpage>560</fpage>&#x02013;566.<pub-id pub-id-type="pmid">16508552</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">Erwin WM. <article-title>The Notochord, Notochordal cell and CTGF/CCN-2: ongoing activity from development through maturation</article-title>. <source>J Cell Commun Signal</source>
<year>2008</year>; <volume>2</volume>: <fpage>59</fpage>&#x02013;65.<pub-id pub-id-type="pmid">19003520</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">Peng B, Chen J, Kuang Z et al. <article-title>Expression and role of connective tissue growth factor in painful disc fibrosis and degeneration</article-title>. <source>Spine</source>
<year>2009</year>; <volume>34</volume>: <fpage>E178</fpage>&#x02013;E182.<pub-id pub-id-type="pmid">19247157</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">Tran CM, Schoepflin ZR, Markova DZ et al. <article-title>CCN2 suppresses catabolic effects of interleukin-1 beta(il-1beta) through alpha5beta1 and alphavbeta3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration</article-title>. <source>J Biol Chem</source>
<year>2014</year>; <volume>289</volume>: <fpage>7374</fpage>&#x02013;7387.<pub-id pub-id-type="pmid">24464580</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">Nishida T, Kawaki H, Baxter RM et al. <article-title>CCN2 (connective tissue growth factor) is essential for extracellular matrix production and integrin signaling in chondrocytes</article-title>. <source>J Cell Commun Signal</source>
<year>2007</year>; <volume>1</volume>: <fpage>45</fpage>&#x02013;58.<pub-id pub-id-type="pmid">18481209</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">Wipff PJ, Hinz B. <article-title>Integrins and the activation of latent transforming growth factor beta1&#x02014;an intimate relationship</article-title>. <source>Eur J Cell Biol</source>
<year>2008</year>; <volume>87</volume>: <fpage>601</fpage>&#x02013;615.<pub-id pub-id-type="pmid">18342983</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">Gleizes PE, Munger JS, Nunes I et al. <article-title>TGF-beta latency: biological significance and mechanisms of activation</article-title>. <source>Stem Cells</source>
<year>1997</year>; <volume>15</volume>: <fpage>190</fpage>&#x02013;197.<pub-id pub-id-type="pmid">9170210</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">Lotz JC. <article-title>Animal models of intervertebral disc degeneration: lessons learned</article-title>. <source>Spine</source>
<year>2004</year>; <volume>29</volume>: <fpage>2742</fpage>&#x02013;2750.<pub-id pub-id-type="pmid">15564923</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">Alini M, Eisenstein SM, Ito K et al. <article-title>Are animal models useful for studying human disc disorders/degeneration?</article-title>
<source>Eur Spine J</source>
<year>2008</year>; <volume>17</volume>: <fpage>2</fpage>&#x02013;19.<pub-id pub-id-type="pmid">17632738</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">Ellis K, Bagwell J, Bagnat M. <article-title>Notochord vacuoles are lysosome-related organelles that function in axis and spine morphogenesis</article-title>. <source>J Cell Biol</source>
<year>2013</year>; <volume>200</volume>: <fpage>667</fpage>&#x02013;679.<pub-id pub-id-type="pmid">23460678</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal">Smith LJ, Nerurkar NL, Choi KS et al. <article-title>Degeneration and regeneration of the intervertebral disc: lessons from development</article-title>. <source>Dis Model Mech</source>
<year>2011</year>; <volume>4</volume>: <fpage>31</fpage>&#x02013;41.<pub-id pub-id-type="pmid">21123625</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">Zhu Y, Ohba T, Ando T et al. <article-title>Endogenous TGF-beta activity limits TSLP expression in the intervertebral disc tissue by suppressing NF-kappaB activation</article-title>. <source>J Orthop Res</source>
<year>2013</year>; <volume>31</volume>: <fpage>1144</fpage>&#x02013;1149.<pub-id pub-id-type="pmid">23483604</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">Wu Q, Wang J, Skubutyte R et al. <article-title>Smad3 controls beta-1,3-glucuronosyltransferase 1 expression in rat nucleus pulposus cells: implications of dysregulated expression in disc disease</article-title>. <source>Arthritis Rheum</source>
<year>2012</year>; <volume>64</volume>: <fpage>3324</fpage>&#x02013;3333.<pub-id pub-id-type="pmid">22674034</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">Yang SH, Lin CC, Hu MH et al. <article-title>Influence of age-related degeneration on regenerative potential of human nucleus pulposus cells</article-title>. <source>J Orthop Res</source>
<year>2010</year>; <volume>28</volume>: <fpage>379</fpage>&#x02013;383.<pub-id pub-id-type="pmid">19780199</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">Gilchrist CL, Chen J, Richardson WJ et al. <article-title>Functional integrin subunits regulating cell-matrix interactions in the intervertebral disc</article-title>. <source>J Orthop Res</source>
<year>2007</year>; <volume>25</volume>: <fpage>829</fpage>&#x02013;840.<pub-id pub-id-type="pmid">17318895</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">Kurakawa T, Kakutani K, Morita Y et al. <article-title>Functional impact of integrin alpha5beta1 on the homeostasis of intervertebral discs: a study of mechanotransduction pathways using a novel dynamic loading organ culture system</article-title>. <source>Spine J</source>
<year>2014</year>; <volume>15</volume>: <fpage>417</fpage>&#x02013;426.<pub-id pub-id-type="pmid">25546513</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">Perbal B. <article-title>CCN proteins: multifunctional signalling regulators</article-title>. <source>Lancet</source>
<year>2004</year>; <volume>363</volume>: <fpage>62</fpage>&#x02013;64.<pub-id pub-id-type="pmid">14723997</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">Chandran PL, Horkay F. <article-title>Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications</article-title>. <source>Acta Biomater</source>
<year>2012</year>; <volume>8</volume>: <fpage>3</fpage>&#x02013;12.<pub-id pub-id-type="pmid">21884828</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">Jin H, Shen J, Wang B et al. <article-title>TGF-beta signaling plays an essential role in the growth and maintenance of intervertebral disc tissue</article-title>. <source>FEBS Lett</source>
<year>2011</year>; <volume>585</volume>: <fpage>1209</fpage>&#x02013;1215.<pub-id pub-id-type="pmid">21420963</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">Abbott RD, Purmessur D, Monsey RD et al. <article-title>Degenerative grade affects the responses of human nucleus pulposus cells to link-N, CTGF, and TGFbeta3</article-title>. <source>J Spinal Disord Tech</source>
<year>2013</year>; <volume>26</volume>: <fpage>E86</fpage>&#x02013;E94.<pub-id pub-id-type="pmid">22907063</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">Gruber HE, Hoelscher GL, Ingram JA et al. <article-title>Variations in aggrecan localization and gene expression patterns characterize increasing stages of human intervertebral disk degeneration</article-title>. <source>Exp Mol Pathol</source>
<year>2011</year>; <volume>91</volume>: <fpage>534</fpage>&#x02013;539.<pub-id pub-id-type="pmid">21689646</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">Lee S, Moon CS, Sul D et al. <article-title>Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus</article-title>. <source>Clin Biochem</source>
<year>2009</year>; <volume>42</volume>: <fpage>1504</fpage>&#x02013;1511.<pub-id pub-id-type="pmid">19563795</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">Murakami H, Yoon ST, Attallah-Wasif ES et al. <article-title>The expression of anabolic cytokines in intervertebral discs in age-related degeneration</article-title>. <source>Spine</source>
<year>2006</year>; <volume>31</volume>: <fpage>1770</fpage>&#x02013;1774.<pub-id pub-id-type="pmid">16845348</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">Nerlich AG, Bachmeier BE, Boos N. <article-title>Expression of fibronectin and TGF-beta1 mRNA and protein suggest altered regulation of extracellular matrix in degenerated disc tissue</article-title>. <source>Eur Spine J</source>
<year>2005</year>; <volume>14</volume>: <fpage>17</fpage>&#x02013;26.<pub-id pub-id-type="pmid">15340826</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">Kwon YJ, Lee JW, Moon EJ et al. <article-title>Anabolic effects of Peniel 2000, a peptide that regulates TGF-beta1 signaling on intervertebral disc degeneration</article-title>. <source>Spine</source>
<year>2013</year>; <volume>38</volume>: <fpage>E49</fpage>&#x02013;E58.<pub-id pub-id-type="pmid">23124260</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">Chan SC, Ferguson SJ, Gantenbein-Ritter B. <article-title>The effects of dynamic loading on the intervertebral disc</article-title>. <source>Eur Spine J</source>
<year>2011</year>; <volume>20</volume>: <fpage>1796</fpage>&#x02013;1812.<pub-id pub-id-type="pmid">21541667</pub-id></mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">Colombier P, Clouet J, Hamel O et al. <article-title>The lumbar intervertebral disc: From embryonic development to degeneration</article-title>. <source>Joint Bone Spine</source>
<year>2013</year>; <volume>81</volume>: <fpage>125</fpage>&#x02013;129.<pub-id pub-id-type="pmid">23932724</pub-id></mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">Hadjipavlou AG, Tzermiadianos MN, Bogduk N et al. <article-title>The pathophysiology of disc degeneration: a critical review</article-title>. <source>J Bone Joint Surg Br</source>
<year>2008</year>; <volume>90</volume>: <fpage>1261</fpage>&#x02013;1270.<pub-id pub-id-type="pmid">18827232</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">Kepler CK, Ponnappan RK, Tannoury CA et al. <article-title>The molecular basis of intervertebral disc degeneration</article-title>. <source>Spine J</source>
<year>2013</year>; <volume>13</volume>: <fpage>318</fpage>&#x02013;330.<pub-id pub-id-type="pmid">23537454</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="fig1"><label>Figure 1</label><caption><p>Mechanical instability induces activation of TGF&#x003b2;, and reduces NC cell vacuoles. (<bold>a</bold>) Safranin O-Fast green staining of IVD sections from wild-type mice from E-16.0 to 4 months after birth. (<bold>b</bold>) Immunostaining of IVD sections showing the expression of aggrecan. <italic>n=6</italic> per time point. (<bold>c</bold>) The height of IVD indicated by the double-headed arrow was measured in <bold>a</bold>. (<bold>d</bold>) Lumbar spine instability mouse model (LSI). Mouse L<sub>3</sub>&#x02013;L<sub>5</sub> spinous processes were resected along with the supraspinous and interspinous ligaments to induce instability of lumbar spine. (This diagram was drawn by the author and has been published in <italic>Scientific Reports</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/articles/srep27093/figure/1">http://www.nature.com/articles/srep27093/figure/1</ext-link>). (<bold>e</bold>) Representative Safranin O staining images of the IVD sections showing the changes of NC cells in LSI and sham-operated 2-month-old mice at 0, 1, 2 and 4 weeks (w) post surgery. (<bold>f</bold>) Representative immunostaining images of IVD sections with antibody against pSmad2/3 (brown). Hematoxylin stains nuclei purple. (<bold>g</bold>) Evaluation of IVD degeneration by IVD score. (<bold>h</bold>) Quantification of pSmad2/3<sup>+</sup> cells in f. <italic>n=6</italic> per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (two-sided Student&#x02019;s <italic>t</italic> test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f1"/></fig><fig id="fig2"><label>Figure 2</label><caption><p>Mechanical instability stimulates extracellular aggrecan. (<bold>a</bold>) Immunofluorescence staining for CCN2 expression (red). DAPI stains nuclei blue. (<bold>b</bold>) Enlarged images of CCN2 expression in NP, AF and EP at 2 weeks post surgery. (<bold>c</bold>) Quantification of CCN2 expression in <bold>a</bold>. (<bold>d</bold>) Representative images of immunofluorescence staining for aggrecan (Acan, red). DAPI stains nuclei blue. (<bold>e</bold>) Quantitative analysis of Acan<sup>+</sup> area in NC cells. <italic>n=6</italic> per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (two-sided Student&#x02019;s <italic>t</italic> test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f2"/></fig><fig id="fig3"><label>Figure 3</label><caption><p>Integrin &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> induces TGF&#x003b2; activation in response to mechanical stress. (<bold>a</bold>&#x02013;<bold>h</bold>) Representative images and quantification of immunostaining of IVD sections with antibodies against (<bold>a</bold>, <bold>b</bold>) &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub>, (<bold>c</bold>, <bold>d</bold>) &#x003b2;8, (<bold>e</bold>, <bold>f</bold>) &#x003b1;<sub>V</sub>&#x003b2;<sub>5</sub>, and (<bold>g</bold>, <bold>h</bold>) &#x003b1;<sub>V</sub>&#x003b2;<sub>3</sub> (brown) in LSI and sham mice. Hematoxylin stains nuclei purple. <italic>n</italic>=6 per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (two-sided Student&#x02019;s <italic>t</italic> test). (<bold>i</bold>) Immunostaining for pSmad2/3 in the NC cells (brown). Hematoxylin stains nuclei purple. (<bold>j</bold>) Safranin O staining of IVD sections from an IVD <italic>ex vivo</italic> compression model with application of either Veh (rows 1 and 3), recombinant mouse TGF&#x003b2;1 (row 2), RGD peptide, TGF&#x003b2; or &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> neutralizing antibodies (bottom 3 rows). (<bold>k</bold>) Quantification of pSmad2/3<sup>+</sup> cells in <bold>i</bold>. (<bold>l</bold>) Western blot analysis of pSmad2 and total Smad2 levels in the IVD. <italic>n</italic>=6 per group in histological examination. Representative image from three independent experiments were conducted for (<bold>l</bold>). Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (ANOVA).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f3"/></fig><fig id="fig4"><label>Figure 4</label><caption><p>Mechanical stress regulates NC cell function. (<bold>a</bold>, <bold>b</bold>) Immunofluorescence staining of IVD sections for (<bold>a</bold>) CCN2 and (<bold>b</bold>) Acan in the NP (red). DAPI stains nuclei blue. (<bold>c</bold>, <bold>d</bold>) Quantification of CCN2 and Acan expression in <bold>a</bold> and <bold>b</bold>. (<bold>e</bold>) Expression of Acan mRNA in NP tissues by quantitative RT-PCR (qRT-PCR). <italic>n</italic>=6 per group in histological examination. Three independent experiments performed in triplicate were conducted for e. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (ANOVA).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f4"/></fig><fig id="fig5"><label>Figure 5</label><caption><p>Conditional knockout of TGF&#x003b2; type II receptor prohibits functional transition of NC cells. (<bold>a</bold>, <bold>b</bold>) Immunostaining of IVD sections from <italic>TgfbrII</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> and their <italic>TgfbrII</italic><sup><italic>+/+</italic></sup> littermates with antibodies against T&#x003b2;RII and pSmad2/3 (brown). Hematoxylin stains nuclei purple. (<bold>c</bold>, <bold>d</bold>) Quantification of T&#x003b2;RII- and pSmad2/3-positive cells in <bold>a</bold> and <bold>b</bold>. (<bold>g</bold>, <bold>h</bold>) Immunofluorescence staining of IVD sections for CCN2 (<bold>g</bold>) and Acan (<bold>h</bold>) (red). DAPI stains nuclei blue. (<bold>e</bold>, <bold>f</bold>) Quantification of CCN2 and Acan in the NC cells in g and h. (<bold>i</bold>) Safranin O-fast green staining of L<sub>3&#x02013;4</sub> IVDs in <italic>TgfbrII</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice and their <italic>TgfbrII</italic><sup><italic>+/+</italic></sup> littermates (4-week-old). (<bold>j</bold>) Quantitative analysis of IVD volumes from &#x003bc;CT scan. <italic>n</italic>=6 per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (two-sided Student&#x02019;s <italic>t</italic> test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f5"/></fig><fig id="fig6"><label>Figure 6</label><caption><p>Conditional knockout of integrin &#x003b1;<sub>v</sub> impedes functional transition of NC cells. (<bold>a</bold>, <bold>b</bold>) Immunostaining of IVD sections from &#x003b1;<sub>v</sub><sup>&#x02212;/&#x02212;</sup> mice and their wild-type &#x003b1;<sub>v</sub><sup>+/+</sup> littermates (4-week-old) with antibodies against &#x003b1;<sub>v</sub> (<bold>a</bold>) and &#x003b2;<sub>6</sub> (<bold>b</bold>) (brown). Hematoxylin stains nuclei purple. (<bold>c</bold>, <bold>d</bold>) Immunostaining for pSmad2/3 (<bold>c</bold>) and &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> (<bold>d</bold>) in NC cells. (<bold>e</bold>, <bold>f</bold>) Immunostaining for CCN2 (<bold>e</bold>) and Acan (<bold>f</bold>) in NC cells. (<bold>g</bold>, <bold>h</bold>) Quantification of pSmad2/3 (<bold>c</bold>) and &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> (<bold>d</bold>) expression in NC cells. (<bold>i</bold>, <bold>j</bold>) Quantification of CCN2 (<bold>i</bold>) and &#x003b1;<sub>V</sub>&#x003b2;<sub>6</sub> (<bold>j</bold>) expression in NC cells. (<bold>k</bold>) Western blot analysis of &#x003b1;<sub>v</sub> level in NC cells. (<bold>l</bold>) Western blot analysis of pSmad2 and Smad2 levels in NC cells. (<bold>m</bold>) Safranin O-fast green staining of L<sub>3&#x02013;4</sub> IVDs showing enlarged vacuoles with less proteoglycans (red orange) in &#x003b1;<sub>v</sub><sup>&#x02212;/&#x02212;</sup> mice relative to their &#x003b1;<sub>v</sub><sup>+/+</sup> littermates (4-week-old). (<bold>n</bold>) Safranin O staining images of the IVDs from sham-operated or LSI <italic>TgfbrII</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice and &#x003b1;<sub>v</sub><sup>&#x02212;/&#x02212;</sup> mice (8-week-old) at 2 weeks post surgery. <italic>n</italic>=3 per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01 (two-sided Student&#x02019;s <italic>t</italic> test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f6"/></fig><fig id="fig7"><label>Figure 7</label><caption><p>Inhibition of excess active TGF&#x003b2; attenuates IVD degeneration in LSI mice. (<bold>a</bold>) IVD score in sham, LSI mice with injection of either Veh or T&#x003b2;RI inhibitor (SB, 1.0&#x02009;mg&#x000b7;kg<sup>&#x02212;1</sup>). (<bold>b</bold>, <bold>e</bold>) Immunostaining and quantification of pSmad2/3 in the NP (brown). Hematoxylin stains nuclei purple. (<bold>c</bold>) Quantification of CCN2 areas in <bold>g</bold>. (<bold>d</bold>) Safranin O staining of L<sub>4&#x02013;5</sub>IVD section. (<bold>f</bold>, <bold>g</bold>) Immunofluorescence staining of IVD sections for Acan (<bold>f</bold>) and CCN2 (<bold>g</bold>) (red). DAPI stains nuclei blue. <italic>n</italic>=6 per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01, <sup>#</sup><italic>P</italic>&#x0003c;0.05, <sup>##</sup><italic>P</italic>&#x0003c;0.01 (ANOVA).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f7"/></fig><fig id="fig8"><label>Figure 8</label><caption><p>Inhibition of excess active TGF&#x003b2; attenuates IVD degeneration in CIC rats and CSI mice. (<bold>a</bold>, <bold>c</bold>, <bold>d</bold>, <bold>h</bold>) Local administration of TGF&#x003b2; neutralizing antibody (1D11, 0.7&#x02009;&#x003bc;g) into the NP of rat caudal IVD compression model (CIC, 12-week-old) prevented IVD degeneration. (<bold>a</bold>) Rat CIC model. Rats were attached with the loading device. The axial stress loaded from the distal side produced a compressive pressure of 1.3 MPa on C<sub>8&#x02013;9</sub> and C<sub>9&#x02013;10</sub> IVDs. The C<sub>8&#x02013;9</sub> of loaded IVDs were injected with an alginate bead containing 1D11 while the C<sub>9&#x02013;10</sub> IVDs with that containing vehicle. (<bold>c</bold>) Safranin O staining of Caudal 8th-9th (C<sub>8&#x02013;9</sub>) IVD with 1D11 or vehicle treatment. Immunostaining and quantification of pSmad2/3<sup>+</sup> cells (<bold>d</bold>, <bold>h</bold>) in the NP of CIC rat (brown). Hematoxylin stains nuclei purple. <italic>n</italic>=6 per group. (<bold>b</bold>, <bold>e</bold>
<bold>g</bold>, <bold>i</bold>
<bold>k</bold>) Caudal SI(CSI) mouse model was induced by full-depth annular stab and NP removal of the C<sub>7&#x02013;8</sub> IVD. (<bold>b</bold>) CSI mouse model. The instability of caudal spine was induced by full-depth annular stab and NP removal of the C<sub>7&#x02013;8</sub> IVD. The adjacent C<sub>8&#x02013;9</sub> IVDs were chosen for observation. The adjacent C<sub>8&#x02013;9</sub> IVDs were chosen for observation. (<bold>e</bold>) Safranin O staining of IVD section. Immunostaining of C<sub>8&#x02013;9</sub>IVD sections with antibodies against (<bold>f</bold>) pSmad2/3 and (<bold>g</bold>) CCN2; (<bold>i</bold>) IVD degeneration was evaluated by IVD score at 4 weeks post surgery. Quantification of (<bold>j</bold>) pSmad2/3<sup>+</sup> cells and (<bold>k</bold>) CCN2<sup>+</sup> expression in <bold>f</bold> and <bold>g</bold>. <italic>n</italic>=6 per group. Data are shown as mean&#x000b1;s.d. *<italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01, <sup>#</sup><italic>P</italic>&#x0003c;0.05, <sup>##</sup><italic>P</italic>&#x0003c;0.01 (ANOVA). (<bold>l</bold>) Model showing mechanosignaling activation of TGF&#x003b2; controls IVD homeostasis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="boneres20178-f8"/></fig></floats-group></article>